Scientists at the University at Buffalo's Institute for Lasers, Photonics and Biophotonics, working with colleagues at the Roswell Park Cancer Institute (RPCI), have developed a non-release, nanoparticle drug delivery system for photodynamic cancer therapy.
Engineers in the Virtual Reality Laboratory at the University at Buffalo have developed a new technology that transmits the sensation of touch over the Internet.
Corticosteroids, drugs that simultaneously deliver powerful therapeutic effects and potentially severe adverse effects, cause a remarkably complex "domino effect" of genomic changes, according to a landmark paper by University at Buffalo pharmaceutical scientists.
Molecular biologists at the University at Buffalo have discovered a novel way to inhibit the replication of poxviruses, the group that includes smallpox virus, by interfering with messenger RNA synthesis necessary for the viruses to reproduce in a host organism.
A tiny lipid particle developed by pharmaceutical scientists at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has the potential to improve significantly the lives of hemophiliacs who have developed a dangerous immune response to the frequent injections of factor VIII, the clotting factor that keeps them alive.
Paras Prasad, SUNY Distinguished Professor in the Department of Chemistry in the University at Buffalo's College of Arts and Sciences, has been honored by the State University of New York for his "singular contribution to scholarship and the reputation of the university." He was one of 14 UB faculty members honored for their research.
The chair. Many view this humble device simply as a means -- sometimes comfortable, sometimes not -- to "take a load off." But for architecture students who completed the seating design assignment in Abir Mullick's "Senior Studio" this spring in the School of Architecture and Planning at the University at Buffalo, the chair became something more.
World-class scientists in the fields of bioinformatics, structural genomics and proteomics will gather next month at a symposium presented by the University at Buffalo Center of Excellence in Bioinformatics to discuss the cutting-edge science essential for advancements in genetic analysis and drug discovery in the post-genomic era.
A new, more powerful method of determining the details of molecular structure will be the topic of an international workshop to be held May 12-17 at the University at Buffalo.